Company Filing History:
Years Active: 2010-2014
Title: Urvi Desai: Innovator in Monoclonal Antibodies
Introduction
Urvi Desai is a prominent inventor based in The Woodlands, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents to her name, her work has the potential to impact the treatment of lipid metabolism disorders.
Latest Patents
Urvi's latest patents include innovative monoclonal antibodies against ANGPTL3 and ANGPTL4. These antibodies specifically bind to their respective targets and neutralize at least one activity of ANGPTL3 and ANGPTL4. Additionally, her patents provide methods for treating disorders of lipid metabolism using these neutralizing monoclonal antibodies.
Career Highlights
Urvi Desai is currently associated with Lexicon Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is crucial in the ongoing quest to find effective treatments for metabolic disorders.
Collaborations
Some of her notable coworkers include E-Chiang Lee and Gregory M Landes, who collaborate with her on various projects within the company.
Conclusion
Urvi Desai's contributions to the field of monoclonal antibodies exemplify her dedication to innovation in biotechnology. Her patents and ongoing research hold promise for future advancements in treating lipid metabolism disorders.